These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26564668)

  • 1. Symmetry in early response to intravitreal ranibizumab in bilateral diabetic macular oedema.
    Guillard M; Dupas B; El Sanharawi M; Erginay A; Tadayoni R; Massin P
    Acta Ophthalmol; 2016 Aug; 94(5):e356-60. PubMed ID: 26564668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal ranibizumab for diabetic macular oedema in previously vitrectomized eyes.
    Laugesen CS; Ostri C; Brynskov T; Lund-Andersen H; Larsen M; Vorum H; Sørensen TL
    Acta Ophthalmol; 2017 Feb; 95(1):28-32. PubMed ID: 27473397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Response between Both Eyes to First- and Second-Line Anti-VEGF Therapy in Diabetic Macular Edema.
    Tiosano L; Ayalon A; Banin E; Averbukh E; Jaouni T; Chowers I
    Curr Eye Res; 2021 Apr; 46(4):539-545. PubMed ID: 32804540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of intravitreal injection of ranibizumab on choroidal structure and blood flow in eyes with diabetic macular edema.
    Okamoto M; Yamashita M; Ogata N
    Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):885-892. PubMed ID: 29492689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Intravitreal Ranibizumab for Diabetic Macular Edema with Serous Retinal Detachment.
    Kaya M; Karahan E; Ozturk T; Kocak N; Kaynak S
    Korean J Ophthalmol; 2018 Aug; 32(4):296-302. PubMed ID: 30091308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of foveal capillary drop-out and previous panretinal photocoagulation for diabetic macular oedema treated with ranibizumab.
    Ebneter A; Wolf S; Zinkernagel MS
    Br J Ophthalmol; 2016 Mar; 100(3):365-70. PubMed ID: 26187951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trials.
    Domalpally A; Ip MS; Ehrlich JS
    Ophthalmology; 2015 Apr; 122(4):779-86. PubMed ID: 25601535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifocal electroretinography changes at the 1-year follow-up in a cohort of diabetic macular edema patients treated with ranibizumab.
    Baget-Bernaldiz M; Romero-Aroca P; Bautista-Perez A; Mercado J
    Doc Ophthalmol; 2017 Oct; 135(2):85-96. PubMed ID: 28779336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RETINAL LAYER RESPONSE TO RANIBIZUMAB DURING TREATMENT OF DIABETIC MACULAR EDEMA: Thinner is Not Always Better.
    Ebneter A; Wolf S; Abhishek J; Zinkernagel MS
    Retina; 2016 Jul; 36(7):1314-23. PubMed ID: 26735563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of baseline diabetic retinopathy status on initial anatomical response of intravitreal ranibizumab therapy for diabetic macular oedema.
    Nicholson L; Patrao NV; Ramu J; Vazquez-Alfageme C; Muwas M; Rajendram R; Hykin PG; Sivaprasad S
    Eye (Lond); 2017 Sep; 31(9):1358-1364. PubMed ID: 28452992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INTRAVITREAL DEXAMETHASONE IMPLANT IN PATIENTS WITH RANIBIZUMAB PERSISTENT DIABETIC MACULAR EDEMA.
    Zhioua I; Semoun O; Lalloum F; Souied EH
    Retina; 2015 Jul; 35(7):1429-35. PubMed ID: 26102440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between macular morphology and treatment frequency during twelve months with ranibizumab for diabetic macular edema.
    Mori Y; Murakami T; Suzuma K; Ishihara K; Yoshitake S; Fujimoto M; Dodo Y; Yoshitake T; Miwa Y; Tsujikawa A
    PLoS One; 2017; 12(4):e0175809. PubMed ID: 28407012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Intravitreal Ranibizumab on Intraretinal Hard Exudates in Eyes with Diabetic Macular Edema.
    Srinivas S; Verma A; Nittala MG; Alagorie AR; Nassisi M; Gasperini J; Sadda SR
    Am J Ophthalmol; 2020 Mar; 211():183-190. PubMed ID: 31758926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The macular function and structure in patients with diabetic macular edema before and after ranibizumab treatment.
    Nowacka B; Kirkiewicz M; Mozolewska-Piotrowska K; Lubiński W
    Doc Ophthalmol; 2016 Apr; 132(2):111-22. PubMed ID: 27000269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The area of fixation covaries with short-term changes in visual acuity after anti-vascular endothelial growth factor treatment in patients with diabetic macular oedema.
    Jakobsen NS; Larsen DA; Bek T
    Acta Ophthalmol; 2018 Nov; 96(7):744-748. PubMed ID: 29687595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.
    Cicinelli MV; Cavalleri M; Querques L; Rabiolo A; Bandello F; Querques G
    Br J Ophthalmol; 2017 Dec; 101(12):1689-1693. PubMed ID: 28432109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of ranibizumab on visual impairment in patients with bilateral diabetic macular edema.
    Fajnkuchen F; Pieramici D; Hrarat L; Best AL; Cohen SY; Delahaye-Mazza C; Grenet T; Nghiem-Buffet S; Quentel G; Bodaghi B; Giocanti-Aurégan A
    Acta Diabetol; 2019 Jan; 56(1):67-71. PubMed ID: 30167869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HYPERREFLECTIVE RETINAL SPOTS AND VISUAL FUNCTION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN CENTER-INVOLVING DIABETIC MACULAR EDEMA.
    Vujosevic S; Berton M; Bini S; Casciano M; Cavarzeran F; Midena E
    Retina; 2016 Jul; 36(7):1298-308. PubMed ID: 26689274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of serous retinal detachment on the outcome of ranibizumab treatment in diabetic macular oedema.
    Ercalik NY; Imamoglu S; Turkseven Kumral E; Yenerel NM; Bardak H; Bardak Y
    Cutan Ocul Toxicol; 2018 Dec; 37(4):324-327. PubMed ID: 29619858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and morphological changes in diabetic macular edema over the course of anti-vascular endothelial growth factor treatment.
    Reznicek L; Cserhati S; Seidensticker F; Liegl R; Kampik A; Ulbig M; Neubauer AS; Kernt M
    Acta Ophthalmol; 2013 Nov; 91(7):e529-36. PubMed ID: 23647578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.